References
- Dheda K, Gumbo T, Maartens G, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017;5(4):291–360. doi:10.1016/S2213-2600(17)30079-6
- World Health Organization. Global tuberculosis report 2018. Available from: http://www.who.int/tb/publications/global_report/en/ Accessed 66, 2019.
- Tuberculosis surveillance and monitoring report in Europe 2019. WHO and ECDC report. Available from: http://www.euro.who.int/en/health-topics/communicable-diseases/tuberculosis/publications/2019/tuberculosis-surveillance-and-monitoring-report-in-europe-2019 Accessed 101, 2019.
- Tuberculosis surveillance and monitoring in Europe 2018. European Centre for Disease Prevention and Control. Available from: https://ecdc.europa.eu/sites/portal/files/documents/ecdc-tuberculosis-surveillance-monitoring-Europe-2018-19mar2018.pdf Accessed 101, 2019.
- Falzon D, Mirzayev F, Wares F, et al. Multidrug-resistant tuberculosis around the world: what progress has been made? Eur Respir J. 2015;45(1):150–160. doi:10.1183/09031936.0010181425261327
- Jenkins HE, Crudu V, Soltan V, Ciobanu A, Domente L, Cohen T. High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova. Eur Respir J. 2014;43(4):1132–1141. doi:10.1183/09031936.0020361324558181
- Pareek M, Greenaway C, Noori T, Munoz J, Zenner D. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med. 2016;14:48. doi:10.1186/s12916-016-0595-527004556
- D’Ambrosio L, Centis R, Dara M, et al. European policies in the management of tuberculosis among migrants. Int J Infect Dis. 2017;56:85–89. doi:10.1016/j.ijid.2016.11.00227836793
- Hargreaves S, Lönnroth K, Nellums LB, et al. Multidrug-resistant tuberculosis and migration to Europe. Clin Microbiol Infect. 2017;23(3):141–146. doi:10.1016/j.cmi.2016.09.00927665703
- Sañé Schepisi M, Scognamiglio P, D’Amato M, Girardi E, Puro V. Letter to the editor: trends in tuberculosis notification rates by country of origin in the metropolitan area of Rome, 2010 to 2015. Euro Surveill. 2017;22(27). doi:10.2807/1560-7917.ES.2017.22.27.30570
- WHO report on TB in the European region, 2018. What constitutes an effective and efficient package of services for the prevention, diagnosis, treatment and care of tuberculosis among refugees and migrants in the WHO European region? Available from: http://www.euro.who.int/__data/assets/pdf_file/0003/371145/who-hen-report-56.pdf?ua=1 Accessed 101, 2019.
- Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006;61(2):158–163. Epub 2005 Oct 27. doi:10.1136/thx.2005.04596316254056
- INMI-guidelines for management of tuberculosis. Available from: http://www.inmi.it/linee_guida/Protocollo%20Tubercolosi%20Rev.%207_2017.pdf Accessed 101, 2019.
- Sotgiu G, Dara M, Centis R, et al. Breaking the barriers: migrants and tuberculosis. Presse Med. 2017;46(2 Pt 2):e5–e11. doi:10.1016/j.lpm.2017.01.01328256381
- Hollo V, Beauté J, Ködmön C, van der Werf MJ. Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015. Euro Surveill. 2017;22(12). doi:10.2807/1560-7917.ES.2017.22.12.30486
- Theron G, Jenkins HE, Cobelens F, et al. Data for action: collection and use of local data to end tuberculosis. Lancet. 2015;386(10010):2324–2333. doi:10.1016/S0140-6736(15)00321-926515676
- Bollettino tubercolosi regione Lazio anni 2005–2017. Servizio Regionale per l’Epidemiologia Sorveglianza e Controllo delle Malattie Infettive (SERESMI). Available from: http://www.inmi.it/file/seresmi/Tubercolosi.%20Lazio%202005-2017.pdf Accessed 101, 2019.
- Mustazzolu A, Borroni E, Cirillo DM, Giannoni F, Iacobino A, Fattorini L. Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009–2016. Eur Respir J. 2018;52:1800070. doi:10.1183/13993003.00070-201829724919
- Del Giudice A, Mustazzolu A, Iacobino A, et al. Drug-resistant tuberculosis in Naples, 2008–2013. Ann Ist Super Sanita. 2016;52(4):603–607. doi:10.4415/ANN_16_04_2327999235
- Matteelli A, Centis R, Sulis G, Tadolini M. Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe. Travel Med Infect Dis. 2016;14(6):588–590. doi:10.1016/j.tmaid.2016.11.01727913312
- Dara M, Sulis G, Centis R, et al. Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences. Int J Tuberc Lung Dis. 2017;21(7):727–736. doi:10.5588/ijtld.16.094028633696